Previous Article |
Table of Contents
| Next Article
* Department of Pharmacology and § Neurosciences and
Communicated by Edward M. Scolnick, Merck & Company, Inc., West Point, PA, September 17, 2001 (received for review July 30, 2001)
A basic assumption about the normal nervous system is that its
neurons possess identical genomes. Here we present direct evidence for
genomic variability, manifested as chromosomal aneuploidy, among
developing and mature neurons. Analysis of mouse embryonic cerebral
cortical neuroblasts in situ detected lagging
chromosomes during mitosis, suggesting the normal generation of
aneuploidy in these somatic cells. Spectral karyotype analysis
identified The mammalian central nervous
system is remarkable for its high degree of organization among vastly
heterogeneous cell types of varied function. The molecular basis for
this heterogeneity is thought to involve complex regulation, at both
transcriptional (1) and posttranscriptional levels (2), of large and
diverse gene families (3, 4). These and virtually all other mechanisms implicated in brain development, function, and disease are assumed to
operate on a constant genome.
Indirect evidence for some form of somatic genomic alteration has come
from nervous system expression and neurogenetic effects of a growing
list of molecules that function in DNA recombination/repair and
surveillance (5-14). Interestingly, many of these genes are also
implicated in cancer, where a commonly associated sequela is
aneuploidy. Precedent exists for aneuploidy during early mammalian development (15, 16) where it is thought to result in cell death. These
observations led us to ask whether the number of chromosomes in
neuroblasts and neurons is variable.
Immunohistochemistry.
Immunohistochemistry was performed as described (17). The primary
anti-nestin (PharMingen) and anti-phosphorylated histone H3
(phospho-H3; Upstate Biotechnology, Lake Placid, NY) Abs were detected
with a Cy3-conjugated secondary IgG (Jackson ImmunoResearch). High-power images of mitotic neuroblasts were acquired and processed by
using a DeltaVision deconvolution microscope (Applied Precision, Seattle, WA). For microtubule-associated protein 2 (MAP2) staining of
adult male brain, sections that had been hybridized with X and Y
chromosome paints and imaged were subsequently stained with a
monoclonal MAP2 Ab (Sigma) and an anti-mouse Cy3 secondary IgG (Jackson
ImmunoResearch). Cells identified previously as aneuploid, based on
fluorescence in situ hybridization (FISH), were reimaged after MAP2 immunohistochemistry. Images were prepared by using PHOTOSHOP (Adobe Systems, Mountain View, CA).
Cell Preparation.
Animal protocols have been approved by the Animal Subjects Committee at
the University of California, San Diego, and conform to National
Institutes of Health guidelines and public law. BALB/c mice (Simonsen
Laboratories, Gilroy, CA) were used for these analyses. Timed-pregnant
females were killed by cervical dislocation, and the embryos were
removed at the appropriate age [embryonic day (E) 11-E15)]. Cortical
neuroblasts and splenic lymphocytes were obtained by using standard
techniques (18, 19). Intact hemispheres were cultured in the presence
of 50 ng/ml of fibroblast growth factor 2 (FGF-2; GIBCO/BRL)
containing OptiMem (GIBCO/BRL) by using described methods (20, 21).
Spectral Karyotype (SKY).
Chromosome spreads were obtained from all cell types by using standard
protocols (19). SKY and 4',6-diamidino-2-phenylindole (DAPI; Sigma)
staining were performed according to manufacturer's instructions
(Applied Spectral Imaging, Carlsbad, CA). Images of chromosome spreads
were acquired by using a Zeiss ×63 or ×100 objective with an
interferometer and charge-coupled device camera (Applied
Spectral Imaging).
FISH.
Interphase nuclei from embryonic and adult cerebral cortex were
harvested for FISH by detergent-lysis, centrifuged at 500 × g, and affixed to glass slides (19). Frozen sections
of adult brain (10-14 µm) were prepared by using immunohistochemical
protocols. Hybridization with X and Y chromosome paints (Applied
Spectral Imaging) was performed per manufacturer's instructions.
Nuclei (300) from each animal were examined for X and Y chromosome
hybridization signals. Nuclei were not counted if both X and Y
signals were absent. Images were captured with a charge-coupled device
camera and prepared by using PHOTOSHOP.
Flow Cytometric Analysis of DNA Content.
Lymphocytes and neuroblasts were stained with propidium iodide, and DNA
content was determined by flow cytometry as described (22). Chick
erythrocyte nuclei (Biosure, Grass Valley, CA) were used at one-tenth
the sample concentration. Cerebral cortices of E12 embryos were
prepared as for SKY, and paired hemispheres were analyzed separately.
One hemisphere was prepared immediately for flow cytometry, whereas the
other was cultured for 2 days in FGF-2 before analysis by flow cytometry.
Lagging Chromosomes in Mitotic Cerebral Cortical Neuroblasts.
We examined proliferating cerebral cortical neuroblasts isolated
from E11 to E17, the period of neurogenesis in mice (23). Postmitotic
cortical neurons arise from neuroblasts located in the ventricular
zone, a region lining the lateral ventricles of the cerebral
hemispheres (24). Neuroblasts can be identified by their birthdate (23)
and immunoreactivity for the intermediate filament protein, nestin
(ref. 25; Fig. 1A). Such
combined birthdating and immunohistochemical analyses of embryonic
preparations used in this study indicated that over 95% of examined
cells were nestin-immunoreactive neuroblasts (data not shown).
Neurobiology
Chromosomal variation in neurons of the developing and adult
mammalian nervous system
,
,
,
,§,
, and
,§,¶
Biomedical Sciences Programs, School of Medicine,
University of California, San Diego, CA 92093-0636
![]()
Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
33% of neuroblasts as aneuploid. Most cells lacked one
chromosome, whereas others showed hyperploidy, monosomy, and/or
trisomy. The prevalence of aneuploidy was reduced by culturing cortical
explants in medium containing fibroblast growth factor 2. Interphase
fluorescence in situ hybridization on embryonic cortical
cells supported the rate of aneuploidy observed by spectral karyotyping
and detected aneuploidy in adult neurons. Our results demonstrate that
genomes of developing and adult neurons can be different at the level of whole chromosomes.
![]()
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (75K):
[in a new window]
Fig. 1.
Mitotic neuroblasts in the embryonic mouse cortex with lagging
chromosomes. (A and B) Low magnification
(×20) micrographs of the embryonic cerebral cortex. Immunofluorescence
for the intermediate filament protein nestin (A), a
neural progenitor cell marker, illustrates the distribution of
neuroblasts in the ventricular zone (VZ) of the embryonic cerebral
cortex. Phospho-H3 labeling (B, red) reveals mitotic
neuroblasts concentrated at the ventricular surface (bottom) of the VZ.
Nuclei are counterstained with DAPI (blue).
(C-F) High magnification (×100) Z
stacks from deconvolution microscopy of phospho-H3-labeled mitotic
figures at the bottom of the VZ reveal morphologically normal
prometaphase/metaphase (C) and anaphase
(D) profiles. In addition, lagging chromosomes (arrows)
are readily observed in prometaphase/metaphase (E) and
anaphase (F) profiles.
Aneuploid Neuroblasts Identified by SKY.
We used SKY (30) to assess chromosomal number and identity in
neuroblasts. In mice, karyotype analysis is technically demanding because mouse chromosomes are acrocentric and of similar size. The SKY
technique uses labeled DNA probes to "paint" each chromosome a
spectral color with a unique combination of fluorophores. Analysis software interprets the spectral color and assigns a chromosomal identity to prometaphase/metaphase genomic DNA. Over 220 cortical neuroblasts, 7-fold more than typically analyzed in SKY studies (12,
14), were karyotyped by SKY from 40 BALB/c embryos (Fig. 2A). SKY revealed a range of
numerical chromosomal abnormalities in neuroblasts, including trisomies
(Fig. 2B) and multiple monosomies (Fig. 2
B and C); no obvious structural abnormalities
were consistently observed. Approximately 33% of neuroblasts were
aneuploid (Table 1), with 98% of these
hypoploid (Fig. 3B). Individual
chromosomes were observed missing at
rates from 1.6% to 8.4% (Fig. 2D) and were gained at rates
of less than 2% (Fig. 2E). Similar results were
obtained in other mouse strains (data not shown). In striking contrast,
routine karyotyping of lymphocytes (31) identified only 3 aneuploid
spreads of 88 observed (
3%) from the parents of embryos used (Table
1). This low rate of lymphocyte aneuploidy is consistent with previous
reports in humans and mice (32-34) and is significantly different
(P < 10
7) from that observed
in neuroblasts.
|
|
|
Aneuploidy Altered by Culturing with FGF-2.
To examine whether the rate of neuroblast aneuploidy could be altered
experimentally, intact cortical hemispheres were cultured for 2 days
in vitro with FGF-2, a well documented neuroblast mitogen that promotes the growth of less differentiated cells (35), before SKY
analysis. This approach allowed us to alter a single variable
growth
condition
in otherwise identical preparations (Fig. 3A).
Culturing reduced the overall prevalence of aneuploidy to 14%,
compared with a rate of 33% in freshly isolated neuroblasts (P < 0.001; Table 1 and Fig. 3 B and
C). This result indicated that the proportion of aneuploid
cells could be experimentally reduced by growth conditions.
Interestingly, the reduction in aneuploidy appears to be the result of
the preferential loss of those cells with greater than one chromosome
gained or lost, because the population missing just one chromosome
remained comparatively unchanged (Fig. 3 B and
C).
Aneuploid Neurons Identified by Interphase FISH. To assess the rate of aneuploidy in interphase embryonic neuroblasts and neurons, we optimized two-color FISH by using X and Y chromosome paints (XY FISH) on samples from male (XY) mice (Fig. 4A). Chromosome paints hybridize to sequences along the entire length of a chromosome, providing better chromosome detection compared with point probes. The use of paints for two different chromosomes controlled against hybridization-dependent false negatives. Analysis of sex chromosomes in males with a red X paint and a green Y paint allowed less ambiguous detection than for an autosomal pair.
|
1%) in both
populations (Table 2) and matched the
rate of sex chromosome loss measured by SKY (data not shown).
Application of this approach to embryonic cerebral cortical cells
revealed that 5.90% of these nuclei were missing an X or Y chromosome,
whereas 0.84% of nuclei had gained an X or Y (Table 2). This result
agrees with the
8% loss and 2% gain measured in neuroblast
prometaphase/metaphase spreads by SKY (Fig. 2 D and
E).
|
10 µm; Table 2; ref. 36). Adult
nuclei were missing an X or Y chromosome at a rate of 1.01%, whereas 0.15% had gained an X or Y (Table 2). These rates, as with all XY FISH
measurements, were lower than the rate of aneuploidy measured by SKY
(33%). XY FISH analysis measured only sex chromosome gain and loss,
whereas SKY data assessed all chromosomes (Fig. 2 D and
E). Therefore, the overall percentage of aneuploid cells in the adult cortex is likely to be higher than that measured with XY
FISH.
Aneuploid nuclei from the adult cortex were likely neuronal based
on their large diameters, but positive identification was complicated
by loss of cytoskeletal antigens during nuclear isolation. To determine
the cellular identity of aneuploid nuclei, XY FISH was combined with
immunohistochemistry on adult tissue sections. Aneuploid nuclei were
identified in adult cortical cells that were also immunoreactive for
the neuronal marker, MAP2 (Fig. 5; ref.
37). MAP2-immunoreactive aneuploid cells were also observed throughout
the central nervous system, including the cerebellum and hippocampus
(data not shown).
|
| |
Discussion |
|---|
|
|
|---|
The fundamental observation of this study is neuroblast aneuploidy. By comparison to an accepted cytogenetic standard, lymphocytes, 10 times as many neuroblasts were aneuploid. This surprising extent of aneuploidy led us to seriously question these results. However, no artifact or combination of artifacts can reasonably explain these data, and multiple lines of evidence supporting the existence of aneuploidy include the following: (i) Lagging chromosomes were commonly seen in neurogenic regions of freshly isolated embryonic cortex. This observation suggests an innate biological mechanism for generating aneuploidy. (ii) Approximately 97% of adult lymphocytes were identified as euploid by SKY and >98% contained both sex chromosomes as measured by XY FISH. Thus, the approaches used in the present study can reliably identify euploid cells. (iii) Some neuroblasts were hyperploid, whereas some hypoploid cells were trisomic for individual chromosomes. This result renders trivial explanations of chromosome loss during sample preparation extremely unlikely. (iv) DNA content measured by flow cytometry is independent of nucleotide hybridization used for SKY and FISH, yet flow cytometry also detected differences in mean DNA content consistent with SKY and XY FISH analyses. In addition, aneuploidy could be altered by culturing as measured by both SKY and flow cytometry. These data demonstrate that aneuploidy, as measured by two different techniques, can be experimentally altered. (v) XY FISH detects aneuploidy at rates comparable to those observed by SKY, despite use of fundamentally different tissue preparations. This observation further demonstrates that aneuploidy cannot be explained by an artifact like sample preparation. From these and other considerations, we conclude that the aneuploidy observed in neuroblasts and neurons is not caused by technical artifact but instead reflects the normal existence of aneuploid neuroblasts.
What is the fate of aneuploid neuroblasts? One probable fate is cell death, as observed in aneuploid embryos during in vitro fertilization (15, 16, 38). The decreased aneuploidy we observed in the adult cortex relative to the embryonic cortex suggests that aneuploid neuroblasts may be preferentially prone to cell death during central nervous system development. This fate is consistent with ongoing programmed cell death normally occurring in neuroproliferative zones (39-41). However, as observed in cancer cells (42), aneuploidy may not necessarily augur death. Our observations of aneuploid interphase neuroblasts during embryonic development and of MAP2-immunoreactive aneuploid cells in the adult brain support the view that a significant population of aneuploid neuroblasts can survive for periods of time, including survival into adulthood as postmitotic neurons. An alternative, but not mutually exclusive, possibility is that mature neurons may also undergo distinct processes resulting in aneuploidy.
Our results indicate that the central nervous system, both during development and in adulthood, is a genetic mosaic: a euploid population intermixed with a smaller but genetically diverse aneuploid population. Such mosaicism may have relevance to a variety of fields including stem cell biology, mammalian cloning, genomics, neurogenetics, and neuropsychiatric diseases. The biological consequences of neural aneuploidy may be similar to X-inactivation, genetic imprinting (43), or allelic inactivation (44). One possibility is that aneuploid neuroblasts and neurons have quantitatively altered signaling properties (45-47) through mechanisms like ploidy-dependent gene expression (48). Aneuploidy in solitary non-neoplastic cells may be of little consequence to the organism. However, we note that a hallmark of the nervous system is its myriad connections that form elaborate and functionally essential neural networks. In this setting, the presence of even a few genomically distinct neurons with altered physiology could have substantial effects on networks formed by interconnected cells. At the organismal level, these permanent genomic changes might contribute to physiological and behavioral variation among individuals not accounted for by classical genetics.
| |
Acknowledgements |
|---|
We are grateful to Drs. D. Baltimore, D. Cleveland, and C. Lois for critical reading of this manuscript. We thank C. Akita and M. Fontanoz for technical assistance; C. Cox for copyediting the manuscript; and Drs. M. J. Difilippantonio, K. Arden, L. Geise, F. Canavez, J. J. A. Contos, J. S. Isaacson, N. Fukushima, I. Ishii, and H. L. Borges for helpful discussions. This work was supported by the National Institute of Mental Health and an unrestricted gift from Merck Research Laboratories (to J.C.); by predoctoral support from the National Science Foundation (to D.K.) and a National Institute of General Medical Sciences Pharmacology training grant (to M.J.M. and A.H.Y.); by postdoctoral support from the Pew Latin American Fellows in the Biomedical Sciences and Conselho Nacional de Pesquisas (Brazil) (to S.K.R.) and by a Neuroplasticity of Aging training grant (to M.A.K.).
| |
Abbreviations |
|---|
SKY, spectral karyotype; FISH, fluorescence in situ hybridization; MAP2, microtubule-associated protein 2; En, embryonic day n; FGF-2, fibroblast growth factor 2; DAPI, 4',6-diamidino-2-phenylindole; phospho-H3, phosphorylated histone H3; XY FISH, two-color FISH using X and Y chromosome paints.
| |
Footnotes |
|---|
S.K.R., M.J.M., and D.K. contributed equally to this work.
¶ To whom reprint requests should be addressed at the present address: Department of Molecular Neuroscience, Merck Research Laboratories, San Diego, 3535 General Atomics Court, San Diego, CA 92121. E-mail: jerold_chun{at}merck.com.
| |
References |
|---|
|
|
|---|
| 1. |
Marin, O.
, Anderson, S. A.
& Rubenstein, J. L.
(2000)
J. Neurosci.
20,
6063-6076 |
| 2. | Schmucker, D. , Clemens, J. C. , Shu, H. , Worby, C. A. , Xiao, J. , Muda, M. , Dixon, J. E. & Zipursky, S. L. (2000) Cell 101, 671-684[CrossRef][ISI][Medline] . |
| 3. | Wu, Q. & Maniatis, T. (1999) Cell 97, 779-790[CrossRef][ISI][Medline] . |
| 4. |
Yagi, T.
& Takeichi, M.
(2000)
Genes Dev.
14,
1169-1180 |
| 5. | Chun, J. & Schatz, D. G. (1999) Neuron 22, 7-10[CrossRef][ISI][Medline] . |
| 6. | Chun, J. & Schatz, D. G. (1999) Curr. Biol. 9, R251-R253[CrossRef][Medline] . |
| 7. | Rolig, R. L. & McKinnon, P. J. (2000) Trends Neurosci. 23, 417-424[CrossRef][ISI][Medline] . |
| 8. | Lee, Y. & McKinnon, P. J. (2000) Apoptosis 5, 523-529[CrossRef][ISI][Medline] . |
| 9. |
Yang, X.
, Li, W.
, Prescott, E. D.
, Burden, S. J.
& Wang, J. C.
(2000)
Science
287,
131-134 |
| 10. | Gao, Y. , Sun, Y. , Frank, K. M. , Dikkes, P. , Fujiwara, Y. , Seidl, K. J. , Sekiguchi, J. M. , Rathbun, G. A. , Swat, W. , Wang, J. , et al. (1998) Cell 95, 891-902[CrossRef][ISI][Medline] . |
| 11. |
Gu, Y.
, Sekiguchi, J.
, Gao, Y.
, Dikkes, P.
, Frank, K.
, Ferguson, D.
, Hasty, P.
, Chun, J.
& Alt, F. W.
(2000)
Proc. Natl. Acad. Sci. USA
97,
2668-2673 |
| 12. |
Sekiguchi, J.
, Ferguson, D. O.
, Chen, H. T.
, Yang, E. M.
, Earle, J.
, Frank, K.
, Whitlow, S.
, Gu, Y.
, Xu, Y.
, Nussenzweig, A.
& Alt, F. W.
(2001)
Proc. Natl. Acad. Sci. USA
98,
3243-3248 |
| 13. | Gao, Y. , Ferguson, D. O. , Xie, W. , Manis, J. P. , Sekiguchi, J. , Frank, K. M. , Chaudhuri, J. , Horner, J. , DePinho, R. A. & Alt, F. W. (2000) Nature (London) 404, 897-900[CrossRef][Medline] . |
| 14. |
Allen, D. M.
, van Praag, H.
, Ray, J.
, Weaver, Z.
, Winrow, C. J.
, Carter, T. A.
, Braquet, R.
, Harrington, E.
, Ried, T.
, Brown, K. D.
, Gage, F. H.
& Barlow, C.
(2001)
Genes Dev.
15,
554-566 |
| 15. | Voullaire, L. , Slater, H. , Williamson, R. & Wilton, L. (2000) Hum. Genet. 106, 210-217[CrossRef][ISI][Medline] . |
| 16. | Harrison, R. H. , Kuo, H. C. , Scriven, P. N. , Handyside, A. H. & Ogilvie, C. M. (2000) Zygote 8, 217-224[CrossRef][ISI][Medline] . |
| 17. |
Weiner, J. A.
& Chun, J.
(1997)
J. Neurosci.
17,
3148-3156 |
| 18. | Fukushima, N. , Weiner, J. A. & Chun, J. (2000) Dev. Biol. 228, 6-18[CrossRef][ISI][Medline] . |
| 19. | Barch, M. J. , Knutsen, T. & Spurbeck, J. L. (1997) The AGT Cytogenetics Laboratory Manual (Lippincott, Philadelphia). |
| 20. | Rehen, S. K. , Varella, M. H. , Freitas, F. G. , Moraes, M. O. & Linden, R. (1996) Development (Cambridge, U.K.) 122, 1439-1448[Abstract]. |
| 21. | Rehen, S. K. , Neves, D. D. , Fragel-Madeira, L. , Britto, L. R. & Linden, R. (1999) Eur. J. Neurosci. 11, 4349-4356[CrossRef][Medline] . |
| 22. | Capparelli, R. , Cottone, C. , D'Apice, L. , Viscardi, M. , Colantonio, L. , Lucretti, S. & Iannelli, D. (1997) Cytometry 29, 261-266[CrossRef][ISI][Medline] . |
| 23. | Angevine, J. B. & Sidman, R. L. (1961) Nature (London) 192, 766-768[Medline] . |
| 24. | Bayer, S. A. & Altman, J. (1991) Neocortical Development (Raven, New York). |
| 25. | Dahlstrand, J. , Lardelli, M. & Lendahl, U. (1995) Brain Res. Dev. Brain Res. 84, 109-129[Medline] . |
| 26. | Hendzel, M. J. , Wei, Y. , Mancini, M. A. , Van Hooser, A. , Ranalli, T. , Brinkley, B. R. , Bazett-Jones, D. P. & Allis, C. D. (1997) Chromosoma 106, 348-360[CrossRef][ISI][Medline] . |
| 27. |
Cimini, D.
, Howell, B.
, Maddox, P.
, Khodjakov, A.
, Degrassi, F.
& Salmon, E. D.
(2001)
J. Cell. Biol.
153,
517-527 |
| 28. | Shah, J. V. & Cleveland, D. W. (2000) Cell 103, 997-1000[CrossRef][ISI][Medline] . |
| 29. | Abrieu, A. , Kahana, J. A. , Wood, K. W. & Cleveland, D. W. (2000) Cell 102, 817-826[CrossRef][Medline] . |
| 30. | Liyanage, M. , Coleman, A. , du Manoir, S. , Veldman, T. , McCormack, S. , Dickson, R. B. , Barlow, C. , Wynshaw-Boris, A. , Janz, S. , Wienberg, J. , et al. (1996) Nat. Genet. 14, 312-315[CrossRef][ISI][Medline] . |
| 31. | Cimino, M. C. , Tice, R. R. & Liang, J. C. (1986) Mutat. Res. 167, 107-122[ISI][Medline] . |
| 32. | Neurath, P. , DeRemer, K. , Bell, B. , Jarvik & Kato, T. (1970) Nature (London) 225, 281-282[Medline] . |
| 33. | Guttenbach, M. , Koschorz, B. , Bernthaler, U. , Grimm, T. & Schmid, M. (1995) Am. J. Hum. Genet. 57, 1143-1150[ISI][Medline] . |
| 34. | Burns, E. M. , Christopoulou, L. , Corish, P. & Tyler-Smith, C. (1999) J. Cell. Sci. 112, 2705-2714[Abstract]. |
| 35. | Ghosh, A. & Greenberg, M. E. (1995) Neuron 15, 89-103[CrossRef][ISI][Medline] . |
| 36. | Peters, A. , Palay, S. & Webster, H. d. (1976) The Fine Structure of the Nervous System (Saunders, Philadelphia). |
| 37. | Shafit-Zagardo, B. & Kalcheva, N. (1998) Mol. Neurobiol. 16, 149-162[Medline] . |
| 38. | Ogasawara, M. , Aoki, K. , Okada, S. & Suzumori, K. (2000) Fertil. Steril. 73, 300-304[CrossRef][ISI][Medline] . |
| 39. | Blaschke, A. J. , Staley, K. & Chun, J. (1996) Development (Cambridge, U.K.) 122, 1165-1174[Abstract]. |
| 40. | Blaschke, A. J. , Weiner, J. A. & Chun, J. (1998) J. Comp. Neurol. 396, 39-50[CrossRef][ISI][Medline] . |
| 41. | Pompeiano, M. , Blaschke, A. J. , Flavell, R. A. , Srinivasan, A. & Chun, J. (2000) J. Comp. Neurol. 423, 1-12[CrossRef][ISI][Medline] . |
| 42. | Lengauer, C. , Kinzler, K. W. & Vogelstein, B. (1998) Nature (London) 396, 643-649[CrossRef][Medline] . |
| 43. | Ohlsson, R. , Paldi, A. & Graves, J. A. (2001) Trends Genet. 17, 136-141[CrossRef][ISI][Medline] . |
| 44. | Chess, A. , Simon, I. , Cedar, H. & Axel, R. (1994) Cell 78, 823-834[CrossRef][ISI][Medline] . |
| 45. |
Bhalla, U. S.
& Iyengar, R.
(1999)
Science
283,
381-387 |
| 46. |
Koch, C.
& Laurent, G.
(1999)
Science
284,
96-98 |
| 47. |
Weng, G.
, Bhalla, U. S.
& Iyengar, R.
(1999)
Science
284,
92-96 |
| 48. |
Galitski, T.
, Saldanha, A. J.
, Styles, C. A.
, Lander, E. S.
& Fink, G. R.
(1999)
Science
285,
251-254 |
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
A. E. Vendrov, Z. S. Hakim, N. R. Madamanchi, M. Rojas, C. Madamanchi, and M. S. Runge Atherosclerosis Is Attenuated by Limiting Superoxide Generation in Both Macrophages and Vessel Wall Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2714 - 2721. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, R. Wang, and K. Herrup E2F1 Works as a Cell Cycle Suppressor in Mature Neurons J. Neurosci., November 14, 2007; 27(46): 12555 - 12564. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Burns, A. E. Ayoub, J. J. Breunig, F. Adhami, W.-L. Weng, M. C. Colbert, P. Rakic, and C.-Y. Kuan Nestin-CreER Mice Reveal DNA Synthesis by Nonapoptotic Neurons following Cerebral Ischemia Hypoxia Cereb Cortex, November 1, 2007; 17(11): 2585 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mosch, M. Morawski, A. Mittag, D. Lenz, A. Tarnok, and T. Arendt Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease J. Neurosci., June 27, 2007; 27(26): 6859 - 6867. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Forni, C. Scuoppo, I. Imayoshi, R. Taulli, W. Dastru, V. Sala, U. A. K. Betz, P. Muzzi, D. Martinuzzi, A. E. Vercelli, et al. High Levels of Cre Expression in Neuronal Progenitors Cause Defects in Brain Development Leading to Microencephaly and Hydrocephaly J. Neurosci., September 13, 2006; 26(37): 9593 - 9602. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Yan, D. Kaushal, M. Murphy, Y. Zhang, A. Datta, C. Chen, B. Monroe, G. Mostoslavsky, K. Coakley, Y. Gao, et al. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice PNAS, May 9, 2006; 103(19): 7378 - 7383. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Osada, N. Tamamaki, S.-Y. Song, N. Kakazu, Y. Yamazaki, H. Makino, A. Sasaki, T. Hirayama, S. Hamada, K.-A. Nave, et al. Developmental Pluripotency of the Nuclei of Neurons in the Cerebral Cortex of Juvenile Mice J. Neurosci., September 14, 2005; 25(37): 8368 - 8374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kingsbury, B. Friedman, M. J. McConnell, S. K. Rehen, A. H. Yang, D. Kaushal, and J. Chun Aneuploid neurons are functionally active and integrated into brain circuitry PNAS, April 26, 2005; 102(17): 6143 - 6147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Thatcher, S. Peddada, D. H. Yasui, and J. M. LaSalle Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples Hum. Mol. Genet., March 15, 2005; 14(6): 785 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Rehen, Y. C. Yung, M. P. McCreight, D. Kaushal, A. H. Yang, B. S. V. Almeida, M. A. Kingsbury, K. M. S. Cabral, M. J. McConnell, B. Anliker, et al. Constitutional Aneuploidy in the Normal Human Brain J. Neurosci., March 2, 2005; 25(9): 2176 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. B. Yurov, I. Y. Iourov, V. V. Monakhov, I. V. Soloviev, V. M. Vostrikov, and S. G. Vorsanova The Variation of Aneuploidy Frequency in the Developing and Adult Human Brain Revealed by an Interphase FISH Study J. Histochem. Cytochem., March 1, 2005; 53(3): 385 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Herrup, R. Neve, S. L. Ackerman, and A. Copani Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death J. Neurosci., October 20, 2004; 24(42): 9232 - 9239. [Full Text] [PDF] |
||||
![]() |
M. J. McConnell, D. Kaushal, A. H. Yang, M. A. Kingsbury, S. K. Rehen, K. Treuner, R. Helton, E. G. Annas, J. Chun, and C. Barlow Failed Clearance of Aneuploid Embryonic Neural Progenitor Cells Leads to Excess Aneuploidy in the Atm-Deficient But Not the Trp53-Deficient Adult Cerebral Cortex J. Neurosci., September 15, 2004; 24(37): 8090 - 8096. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Yang, D. Kaushal, S. K. Rehen, K. Kriedt, M. A. Kingsbury, M. J. McConnell, and J. Chun Chromosome Segregation Defects Contribute to Aneuploidy in Normal Neural Progenitor Cells J. Neurosci., November 12, 2003; 23(32): 10454 - 10462. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kaushal, J. J. A. Contos, K. Treuner, A. H. Yang, M. A. Kingsbury, S. K. Rehen, M. J. McConnell, M. Okabe, C. Barlow, and J. Chun Alteration of Gene Expression by Chromosome Loss in the Postnatal Mouse Brain J. Neurosci., July 2, 2003; 23(13): 5599 - 5606. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, T. Ueba, B. R. Christie, B. Barkho, M. J. McConnell, K. Nakashima, E. S. Lein, B. D. Eadie, A. R. Willhoite, A. R. Muotri, et al. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function PNAS, May 27, 2003; 100(11): 6777 - 6782. [Abstract] [Full Text] [PDF] |
||||
|
|